Company intelligence / Profile preview
SynCore Biotechnology
Yilan City, Taiwansyncorebio.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
SynCore’s lead program, SB05PC (EndoTAG®‑1), has completed global Phase III interim analyses in metastatic pancreatic cancer. Previous trials did not meet primary endpoints but new protocols are targeting FOLFIRINOX-resistant patients with promising survival extension data. The pipeline includes additional oncology assets in earlier stages as well as products for ophthalmology and dermatology.
- Therapeutic areas
- OphthalmologyOncologyInfectious Diseases
- Modalities
- Small molecules (notably liposomal formulations)Conventional drugs (e.g., paclitaxel liposomal/EndoTAG®‑1)New chemical entities (NCEs)Ointments for dermatology indications
- Industry
- Biotech
02
Drug pipeline
4 assets3 more assets in the full pipeline.
03
Partnerships
Medigene AGMacuCLEAR Inc.Sinphar Pharmaceutical Co., Ltd.National Health Research Institutes TaiwanY-YBar AG SwitzerlandEpipole UK
Beyond the preview
Go deeper on SynCore Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on SynCore Biotechnology.